Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Immunoprecise Antibodies Ltd
(NQ:
IPA
)
1.220
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 24, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
23,274
Open
1.260
Bid (Size)
1.220 (2)
Ask (Size)
1.240 (2)
Prev. Close
1.220
Today's Range
1.210 - 1.260
52wk Range
0.9400 - 4.220
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Epitope Binning Powered By LENSai TM Technology Can Analyze Over 5,000 Sequences With No Physical Materials Needed, Matches Classical Wet Lab Binning Results
April 22, 2024
Via
ACCESSWIRE
ImmunoPrecise Antibodies And InterSystems Partner To Leverage AI In Life Sciences, Transforming Patient Care With Accelerated Discovery And Delivery Of Treatments
April 12, 2024
Via
ACCESSWIRE
Performance
YTD
-28.24%
-28.24%
1 Month
-19.74%
-19.74%
3 Month
-12.86%
-12.86%
6 Month
-2.40%
-2.40%
1 Year
-59.87%
-59.87%
More News
Read More
InterSystems and IPA’s Subsidiary BioStrand Collaborate to Unveil the Innovative Integration of Vector Search with LENSai for AI-Driven Healthcare Applications
March 28, 2024
From
ImmunoPrecise Antibodies Ltd.
Via
Business Wire
Earnings Outlook For ImmunoPrecise Antibodies
March 13, 2024
Via
Benzinga
Earnings Preview For ImmunoPrecise Antibodies
December 13, 2023
Via
Benzinga
EXCLUSIVE: Immunoprecise Antibodies and InterSystems Integrate Vector Search With LENSai For AI-Driven Healthcare Applications
March 28, 2024
Via
Benzinga
IPA Acquires the Carterra LSA® Instrument to Enhance Antibody Discovery and Bolster Its AI Developments
March 20, 2024
From
ImmunoPrecise Antibodies Ltd.
Via
Business Wire
IPA Stock Earnings: ImmunoPrecise Antibodies Misses EPS, Beats Revenue for Q3 2024
March 14, 2024
Via
InvestorPlace
IPA Reports Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2024*
March 14, 2024
From
ImmunoPrecise Antibodies Ltd.
Via
Business Wire
Earnings Scheduled For March 14, 2024
March 14, 2024
Via
Benzinga
ImmunoPrecise Antibodies (NASDAQ:IPA) Subsidiary BioStrand Introduces Breakthrough AI Model In Life Sciences, Harnessing LLM Stacking And HYFT Technology
March 08, 2024
Via
ACCESSWIRE
Why HighPeak Energy Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
March 07, 2024
Via
Benzinga
IPA’s subsidiary BioStrand Unveils Major Breakthrough in Life Sciences with Advanced Foundation AI Model Utilizing LLM Stacking and HYFT Technology
March 07, 2024
From
ImmunoPrecise Antibodies Ltd.
Via
Business Wire
IPA to Report Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2024 on March 14, 2024
March 04, 2024
From
ImmunoPrecise Antibodies Ltd.
Via
Business Wire
ImmunoPrecise Antibodies (NASDAQ:IPA) Is Changing How We Look At The Complex World Of Antibody Discovery
February 13, 2024
Via
ACCESSWIRE
ImmunoPrecise Antibodies (NASDAQ: IPA) Is Changing How We Look At The Complex World Of Antibody Discovery
February 12, 2024
Via
Benzinga
ImmunoPrecise Antibodies Reports A 19.9% Revenue Increase As It Launches The Next Phase Of LENSai Portal And SaaS Platforms
January 10, 2024
Via
ACCESSWIRE
ImmunoPrecise Antibodies Reports A 19.9% Revenue Increase As It Launches The Next Phase Of LENSai Portal And SaaS Platforms
January 09, 2024
Via
Benzinga
IPA Stock Earnings: ImmunoPrecise Antibodies Beats EPS, Beats Revenue for Q2 2024
December 14, 2023
Via
InvestorPlace
IPA Reports Financial Results and Recent Business Highlights for Second Quarter Fiscal Year 2024*
December 14, 2023
From
ImmunoPrecise Antibodies Ltd.
Via
Business Wire
Earnings Scheduled For December 14, 2023
December 14, 2023
Via
Benzinga
IPA Announces Closing of $1.265 Million Public Offering of Common Shares
December 08, 2023
From
ImmunoPrecise Antibodies Ltd.
Via
Business Wire
ImmunoPrecise Antibodies Welcomes Mitch Levine To Its Board Of Directors, To Announce Quarterly Results On December 14
December 07, 2023
Via
ACCESSWIRE
Gold Moves Higher; Campbell Soup Earnings Top Expectations
December 06, 2023
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why AeroVironment Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
December 06, 2023
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.